Marble Raises $30.0M Series

Aippy

Aippy is the community designed to foster a vibrant space where creators can effortlessly build, share, and explore interactive projects using natural language. Founded with a vision to boost inspiring and interactive experiences beyond traditional coding, Aippy makes the entire creation process smoother and more seamless by launching its iOS app, which enables users to speak to generate prompts.

Centrical

Centrical, the AI Performance Experience Platform, empowers best-in-class customer experiences for the world’s leading brands by building highly engaged and productive frontline teams. The platform personalizes the employee experience, guiding individual success and growth through AI-driven performance, coaching and quality management, personalized microlearning, and voice of the employee—all wrapped in industry-leading gamification to make the experience both fun and rewarding. In addition, Centrical’s conversational AI Assistant empowers frontline managers to develop their teams through more effective and efficient coaching. In 2024, Centrical was recognized as a leader by Frost & Sullivan in their Workforce Engagement Management (WEM) Radar™, validating its innovative approach to employee performance and engagement. Centrical was founded in 2013 and serves customers in 150 countries in 40 different languages. Centrical has offices in New York, Tel Aviv, and London, and customers include leading multinational enterprises such as Teleperformance, DHL, Synchrony Financial, and more.

Quantinuum

Science led and enterprise driven, Quantinuum unites Cambridge Quantum’s best-in-class software with Honeywell Quantum Solutions’ high-performing trapped-ion hardware. We are scaling quantum computing and developing applications today to solve the world’s most pressing challenges.

Flourish

The Flourish platform helps RIAs (Registered Investment Advisors) grow by evolving from holistic advice to holistic implementation. The Flourish platform supports more than $8 billion in assets under custody and is used by more than 1100 wealth management firms representing more than $2.6 trillion in assets under management. Flourish is wholly-owned by MassMutual. For more information, visit www.flourish.com.

Goldenrod Therapeutics

Goldenrod Therapeutics is developing a new class of medicine targeting serious neurological conditions — including Friedreich's ataxia, other neurodegenerative diseases, substance use disorders, and immunological diseases. Our approach builds on a well-established biological pathway in the brain, improving on earlier treatments that were held back by side effects and tolerability issues. By achieving meaningful drug exposure in the brain while maintaining a favorable safety profile, we believe we can open the door to treatments that simply weren't possible before — reaching millions of patients with few or no good options today.